These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 18037904)
1. HDAC activity is required for p65/RelA-dependent repression of PPARdelta-mediated transactivation in human keratinocytes. Aarenstrup L; Flindt EN; Otkjaer K; Kirkegaard M; Andersen JS; Kristiansen K J Invest Dermatol; 2008 May; 128(5):1095-106. PubMed ID: 18037904 [TBL] [Abstract][Full Text] [Related]
2. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Ashburner BP; Westerheide SD; Baldwin AS Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889 [TBL] [Abstract][Full Text] [Related]
3. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Hoberg JE; Popko AE; Ramsey CS; Mayo MW Mol Cell Biol; 2006 Jan; 26(2):457-71. PubMed ID: 16382138 [TBL] [Abstract][Full Text] [Related]
4. Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin. Westergaard M; Henningsen J; Johansen C; Rasmussen S; Svendsen ML; Jensen UB; Schrøder HD; Staels B; Iversen L; Bolund L; Kragballe K; Kristiansen K J Invest Dermatol; 2003 Nov; 121(5):1104-17. PubMed ID: 14708613 [TBL] [Abstract][Full Text] [Related]
5. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Liu Y; Smith PW; Jones DR Mol Cell Biol; 2006 Dec; 26(23):8683-96. PubMed ID: 17000776 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-kappaB and histone deacetylase 1 in ventricular myocytes. Shaw J; Zhang T; Rzeszutek M; Yurkova N; Baetz D; Davie JR; Kirshenbaum LA Circ Res; 2006 Dec; 99(12):1347-54. PubMed ID: 17082476 [TBL] [Abstract][Full Text] [Related]
7. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1. Barroso E; Eyre E; Palomer X; Vázquez-Carrera M Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504 [TBL] [Abstract][Full Text] [Related]
8. AP1-dependent repression of TGFα-mediated MMP9 upregulation by PPARδ agonists in keratinocytes. Meissner M; Berlinski B; Doll M; Hrgovic I; Laubach V; Reichenbach G; Kippenberger S; Gille J; Kaufmann R Exp Dermatol; 2011 May; 20(5):425-9. PubMed ID: 21496113 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha. Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902 [TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. Hu J; Colburn NH Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876 [TBL] [Abstract][Full Text] [Related]
12. Exchange of a nuclear corepressor between NF-kappaB and CREB mediates inhibition of phosphoenolpyruvate carboxykinase transcription by NF-kappaB. Yan JH; Gao ZG; Ye JP; Weng JP Chin Med J (Engl); 2010 Jan; 123(2):221-6. PubMed ID: 20137375 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of nuclear factor-kappa B subunits on epidermal keratinocytes by ultraviolet B and tacrolimus. Wu CS; Lan CC; Kuo HY; Chai CY; Chen WT; Chen GS Kaohsiung J Med Sci; 2012 Nov; 28(11):577-85. PubMed ID: 23140765 [TBL] [Abstract][Full Text] [Related]
14. Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65. Nihira K; Ando Y; Yamaguchi T; Kagami Y; Miki Y; Yoshida K Cell Death Differ; 2010 Apr; 17(4):689-98. PubMed ID: 19911008 [TBL] [Abstract][Full Text] [Related]
15. Dimethylcelecoxib induces an inhibitory complex consisting of HDAC1/NF-κB(p65)RelA leading to transcriptional downregulation of mPGES-1 and EGR1. Deckmann K; Rörsch F; Geisslinger G; Grösch S Cell Signal; 2012 Feb; 24(2):460-467. PubMed ID: 21983014 [TBL] [Abstract][Full Text] [Related]
16. HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity. Leus NG; van der Wouden PE; van den Bosch T; Hooghiemstra WTR; Ourailidou ME; Kistemaker LE; Bischoff R; Gosens R; Haisma HJ; Dekker FJ Biochem Pharmacol; 2016 May; 108():58-74. PubMed ID: 26993378 [TBL] [Abstract][Full Text] [Related]
17. High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo. Lehmann A; Denkert C; Budczies J; Buckendahl AC; Darb-Esfahani S; Noske A; Müller BM; Bahra M; Neuhaus P; Dietel M; Kristiansen G; Weichert W BMC Cancer; 2009 Nov; 9():395. PubMed ID: 19912635 [TBL] [Abstract][Full Text] [Related]
18. PI3-kinase and PDK-1 regulate HDAC1-mediated transcriptional repression of transcription factor NF-kappaB. Choi YS; Jeong S Mol Cells; 2005 Oct; 20(2):241-6. PubMed ID: 16267399 [TBL] [Abstract][Full Text] [Related]
19. NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Liu GH; Qu J; Shen X Biochim Biophys Acta; 2008 May; 1783(5):713-27. PubMed ID: 18241676 [TBL] [Abstract][Full Text] [Related]